Journal of Hepatology
Volume 49, Issue 5 , Pages 702-710, November 2008

Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion

  • Naoki Fujita

      Affiliations

    • Department of Gastroenterology and Hepatology, Division of Clinical Medicine and Biomedical Science, Institute of Medical Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 59 231 5017; fax: +81 59 231 5223.
  • ,
  • Ryosuke Sugimoto

      Affiliations

    • Department of Gastroenterology and Hepatology, Division of Clinical Medicine and Biomedical Science, Institute of Medical Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan
  • ,
  • Satoshi Motonishi

      Affiliations

    • Division of Clinical Science, Medical Research Institute, Kanazawa Medical University, Kanzawa, Japan
    • School of Pharmacy, Aichi Gakuin University, Aichi, Japan
  • ,
  • Naohisa Tomosugi

      Affiliations

    • Division of Clinical Science, Medical Research Institute, Kanazawa Medical University, Kanzawa, Japan
  • ,
  • Hideaki Tanaka

      Affiliations

    • Department of Gastroenterology and Hepatology, Division of Clinical Medicine and Biomedical Science, Institute of Medical Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan
  • ,
  • Masaki Takeo

      Affiliations

    • Department of Gastroenterology and Hepatology, Division of Clinical Medicine and Biomedical Science, Institute of Medical Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan
  • ,
  • Motoh Iwasa

      Affiliations

    • Department of Gastroenterology and Hepatology, Division of Clinical Medicine and Biomedical Science, Institute of Medical Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan
  • ,
  • Yoshinao Kobayashi

      Affiliations

    • Department of Gastroenterology and Hepatology, Division of Clinical Medicine and Biomedical Science, Institute of Medical Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan
  • ,
  • Hisao Hayashi

      Affiliations

    • School of Pharmacy, Aichi Gakuin University, Aichi, Japan
  • ,
  • Masahiko Kaito

      Affiliations

    • Department of Gastroenterology and Hepatology, Division of Clinical Medicine and Biomedical Science, Institute of Medical Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan
  • ,
  • Yoshiyuki Takei

      Affiliations

    • Department of Gastroenterology and Hepatology, Division of Clinical Medicine and Biomedical Science, Institute of Medical Sciences, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan

Received 12 January 2008; received in revised form 30 April 2008; accepted 1 May 2008. published online 06 June 2008.

Associate Editor: Y.M. Deugnier

Background/Aims

The aim of this study is to determine the clinical relevance of hepatic producing iron regulatory hormone-hepcidin, on iron overload in patients with chronic hepatitis C (CHC).

Methods

Serum hepcidin was measured in 73 CHC patients by surface-enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS), and compared to those of healthy controls and anemia of inflammation patients, and analyzed their relationship to hepatic hepcidin mRNA expression levels and clinical, hematological, and histological findings. The sequential changes of hepcidin were investigated in 27 CHC patients treated with a 48 week-course of pegylated-interferon (PEG-IFN) plus ribavirin therapy.

Results

Serum hepcidin was positively correlated with hepatic hepcidin mRNA levels, serum ferritin and the degree of hepatic iron deposition in CHC. Serum hepcidin-to-ferritin ratios were significantly lower in HCV positive patients than in HCV negative controls in both hyper- and normal-ferritinemic conditions. This relative impairment of hepcidin production was fully reversible after successful HCV eradication by PEG-IFN plus ribavirin, concomitantly with the improvement of the iron overload condition.

Conclusions

The impairment of hepatic hepcidin production occurring with chronic HCV infection may enhance iron toxicity and lead to disease progression, and modulation or supplementation of hepcidin may be beneficial for these conditions in CHC.

Keywords: Chronic hepatitis C, Iron, Iron-regulated genes, Interferon, Ribavirin, Surface-enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS), Real-time PCR

Abbreviations: CHC, chronic hepatitis C, SELDI-TOF-MS, surface-enhanced laser desorption/ionization time of flight mass spectrometry, PEG, pegylated, IFN, interferon, HCV, hepatitis C virus, AI, anemia of inflammation, SD, standard deviation, CHCA, α-cyano-4-hydroxy-cinnamic acid, AU, arbitrary units, PCR, polymerase chain reaction, TIS, total iron score, SVR, sustained virological responders, IL, interleukin, LPS, lipopolysaccharide

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

PII: S0168-8278(08)00358-9

doi:10.1016/j.jhep.2008.05.014

Journal of Hepatology
Volume 49, Issue 5 , Pages 702-710, November 2008